Clairfield advises Cairdac on its equity raising from Merieux Equity Partners, Supernova Invest, Bpifrance and Turenne Capital (Sham)
Cairdac, a French medtech company that is developing a unique self‐sustainable dual‐chamber leadless pacemaker, raised EUR 17 million from Mérieux Equity Partners, Supernova Invest, Bpifrance, and Sham Innovation Santé (advised by Turenne).
Healthcare
![](https://www.clairfield.com/wp-content/uploads/2022/06/Cairdac.png)
Equity raise
![](https://www.clairfield.com/wp-content/uploads/2022/06/merieux-super-nova-bpi-turenne-h-300x38.jpg)
Advisor to Cairdac
Services :
Sectors :
Countries involved :
Deal team :